To include your compound in the COVID-19 Resource Center, submit it here.

Sunovion submits NDA for dasotraline in ADHD

The Sunovion Pharmaceuticals Inc. subsidiary

Read the full 51 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE